GDF15 linked to maternal risk of nausea and vomiting during pregnancy
University of Southern California · University of Cambridge · +15 more institutions
Abstract
Abstract GDF15, a hormone acting on the brainstem, has been implicated in the nausea and vomiting of pregnancy, including its most severe form, hyperemesis gravidarum (HG), but a full mechanistic understanding is lacking 1–4 . Here we report that fetal production of GDF15 and maternal sensitivity to it both contribute substantially to the risk of HG. We confirmed that higher GDF15 levels in maternal blood are associated with vomiting in pregnancy and HG. Using mass spectrometry to detect a naturally labelled GDF15 variant, we demonstrate that the vast majority of GDF15 in the maternal plasma is derived from the feto-placental unit. By studying carriers of rare and common genetic variants, we found that low…
Citation impact
- FWCI
- 41.16
- Percentile
- 100%
- References
- 43
Authors
43- MSMarlena S. FejzoCorresponding
University of Southern California
- NRNuno Rocha
University of Cambridge, Wellcome/MRC Institute of Metabolic Science, Medical Research Council
- ICIrène Cimino
University of Cambridge, Wellcome/MRC Institute of Metabolic Science, Medical Research Council
- SLSam Lockhart
University of Cambridge, Wellcome/MRC Institute of Metabolic Science, Medical Research Council
- CJClive J. Petry
University of Cambridge, Wellcome/MRC Institute of Metabolic Science, Medical Research Council
Topics & keywords
- GDF15
- Nausea
- Vomiting
- Pregnancy
- Medicine
- Bolus (digestion)
- Obstetrics
- Internal medicine
- Good health and well-being
Funding
- WTWellcome TrustAwards: Z/17/Z, 104036/Z/14/Z, 208363/Z/17/Z, MC_UU_00014/5, 106263/Z/14/Z, 106262/Z/14/Z, 225479/Z/22
- SGScottish GovernmentAward: CZD/16/6
- WCWorld Cancer Research Fund InternationalAward: 2004/03
- NTNewlife the Charity for Disabled ChildrenAward: 07/20
- NINational Institute for Health and Care ResearchAward: MC_UU_00014/5
- DODepartment of Health and Social Care
- SFScottish Funding CouncilAward: HR03006
- DUDiabetes UKAwards: NNF19SA058974, 90795724, 17/0005712
- UOUniversity of Cambridge
- ECEuropean CommissionAwards: 018947, QLK4-1999-01422, LSHG-CT-2006-01947
- UOUniversity of Edinburgh
- EFEuropean Foundation for the Study of DiabetesAward: NNF19SA058974
- CUCambridge University Hospitals
- NNNovo NordiskAward: NNF19SA058974
- NNNovo Nordisk FondenAward: NNF19SA058974
- NINational Institutes of HealthAwards: P01CA196569, R01HG012133, R01GM140287
- CSChief Scientist Office, Scottish Government Health and Social Care Directorate
- MRMedical Research CouncilAwards: G1001995, MC_UU_00014/1, MR/X012417/1, MC_UU_00014/3, 104036/Z/14/Z, MC_UU_12015, MC UU 12012/3, 208363/Z/17/Z, U106179472, MC_UU_00014/5, MC_UU_00014/5, MRC MC UU 12012/3, MC_UU_00014/1, MC_UU_12015/2, G1100221, MC_UU_00007/10, MC_UU_12015/, MR/M009041/1, 7500001180, MC_UU_00007/10, MR/M009041/1, MC_UU_12015/2, MC_UU_00006/2
- WCWorld Cancer Research FundAward: 2004/03
- NCNIHR Cambridge Biomedical Research Centre